Shilpa Medicare (BOM:530549) EPS (Basic): ₹11.39 (TTM As of Mar. 2026)


BOM:530549 Shilpa Medicare Ltd BOM:530549
71 GF Score
Price ₹579.40
GF Value ₹391.01
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Shilpa Medicare EPS (Basic)?

Shilpa Medicare BOM:530549 -1.89% 71 EPS (Basic) is ₹11.39 as of Mar. 2026. GuruFocus rates BOM:530549 with a GF Score™ of 71/100 and a GF Value™ of ₹391.01 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Shilpa Medicare's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹5.51. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹11.39.

Shilpa Medicare's EPS (Diluted) for the three months ended in Mar. 2026 was ₹5.51. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹11.39.

Shilpa Medicare's EPS without NRI for the three months ended in Mar. 2026 was ₹4.37. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 10.74.

During the past 12 months, Shilpa Medicare's average EPS without NRIGrowth Rate was 137.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Shilpa Medicare's highest 3-Year average EPS without NRI Growth Rate was 57.80% per year. The lowest was -32.40% per year. And the median was 9.80% per year.

Shilpa Medicare  (BOM:530549) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shilpa Medicare EPS (Basic) Related Terms

Shilpa Medicare EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Shilpa Medicare's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shilpa Medicare EPS (Basic) Chart

Shilpa Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.63 -1.88 1.84 4.02 12.44

Shilpa Medicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 2.40 1.13 2.36 5.51
BOM:530549
71GF Score
Shilpa Medicare Ltd BOM:530549
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shilpa Medicare EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shilpa Medicare's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2433.3-0)/195.603
=12.44

Shilpa Medicare's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1077.9-0)/195.626
=5.51

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹11.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹11.39 mean?
Shilpa Medicare (BOM:530549) has a EPS (Basic) of ₹11.39 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Shilpa Medicare and its competitors.
Is Shilpa Medicare's EPS (Basic) too high?
Shilpa Medicare's current EPS (Basic) is ₹11.39. Overall, Shilpa Medicare has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shilpa Medicare's EPS (Basic) compare to ZTS?
Shilpa Medicare's EPS (Basic) of ₹11.39 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Shilpa Medicare and its competitors. Shilpa Medicare's current EPS (Basic) is ₹11.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shilpa Medicare stock overvalued right now?
Based on GuruFocus' analysis, Shilpa Medicare (BOM:530549) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹391.01, compared to a current price of ₹579.40 — trading 48.2% above its estimated fair value. The current EPS (Basic) is ₹11.39. Shilpa Medicare's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Shilpa Medicare (BOM:530549), the current EPS (Basic) is ₹11.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shilpa Medicare (BOM:530549) Overvalued in 2026?

Based on GuruFocus' analysis, Shilpa Medicare stock appears to be overvalued. The current stock price of ₹579.40 is trading 48.2% above its estimated GF Value™ of ₹391.01. GuruFocus considers Shilpa Medicare to be Significantly Overvalued.

Key valuation signals for BOM:530549:

  • EPS (Basic): ₹11.39
  • GF Value™: ₹391.01 vs. price of ₹579.40 (48.2% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the BOM:530549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shilpa Medicare Business Description

Other Exchanges SHILPAMED:India
Address Hyderabad Road, No. 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
71GF Score

Get the complete analysis for BOM:530549

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹579.40
Price
₹391.01
GF Value